Synthesis, characterization, in-vitro biological evaluation and theoretical studies of 1,2,3-triazoles derived from triclosan as difenoconazole analogues
作者:Juana Suárez-García、Ma.-Angeles Cano-Herrera、Angela María-Gaviria、Víctor Manuel Osorio-Echeverri、Hugo Mendieta-Zerón、David Arias-Olivares、Julie Benavides-Melo、Luis Carlos García-Sánchez、Josue García-Ortíz、Andrés Becerra-Buitrago、Jessica Valero-Rojas、Mateo Rodríguez-González、Marco Antonio García-Eleno、Erick Cuevas-Yañez
DOI:10.1016/j.molstruc.2023.135053
日期:2023.5
Synthesized 1,2,3-triazoles were evaluated for activity against diverse strains including bacterial strains of Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 700891 and fungal strain Candida albicans ATCC 90028. A 1,2,3-triazole derivative bearing a CH(OH)CH3 group displayed a selective activity against Methicillin-resistant Staphylococcus aureus (MRSA) comparable to Gentamicin standard. This selectivity
描述了新型苯醚甲环唑类似物的有效合成。合成路线包括在三氯生分子上进行 Friedel-Crafts 酰化,然后在单个合成操作中连续形成叠氮化物/CuAAC 反应,从而生成 1-(2-chloro-5-(2,4-dichlorophenoxy)-4-hydroxyphenyl)- 2-(4-(1-hydroxycyclohexyl)-1,2,3-triazol-1-yl)ethan-1-one 衍生物,产率为 50–96%。评估了合成的 1,2,3-三唑对多种菌株的活性,包括金黄色葡萄球菌ATCC 29213、大肠杆菌ATCC 700891 和真菌菌株白色念珠菌ATCC 90028。带有 CH(OH) 的 1,2,3-三唑衍生物)CH 3组显示出对耐甲氧西林的选择性活性金黄色葡萄球菌(MRSA) 与庆大霉素标准品相当。这种选择性可归因于 5-chloro-2-(2,4-dichloro-phenoxy)-phenol